Christopher Morris, MD Professor, Pediatrics School of Medicine

Publications 

  Scholarly Journals--Published

• GD Ferguson, K Jensen-Pergakes, C Wilkey, U Jharveri, N Richard, D Verhelle, LM DeParseval, LG Corral, W Zie, CL Morris, H Brady, and K Chan. . "Immunomodulatory Drug CC-4047 is a Cell-type and stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2." Journal of Clinical Immunology 27(2). (2007): 210-220-. ( 1/2007 )

• CL Morris, Siegel E, Barlogie B, Cottler-Fox M, Lin P, Fassas A, Zangari, M, Anaissie E, and Tricot G. "Mobilization of CD34+ cells in elderly patients (>70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen." British J of Hematology 120. (2003): 413-423-. ( 1/2003 )

• Shaughnessy J Jr, Tian E, Sawyer J, McCoy J, Tricot G, Jacobson J, Anaissie E, Zangari M, Fassas A, Muwalla F, Morris C, Barlogie B. "Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II." British J of Hematology . (2003): 44-52-. ( 1/2003 )

• Lee CK, Badros A, Barlogie B, Morris C, Zangari M, Fassas A, van Rhee F, Cottler-Fox M, Jacobson J, Thertulien R, Muwalla F, Mazher S, Anaissie E, Tricot G. "Prognostic factors in allogeneic transplantion for patients with high-risk multiple myeloma after reduced intensity conditioning." Exp Hematol 31. (2003): 73-80-. ( 1/2003 )

• Fassas ABT, Morris C, Badros A, Van Rhee F, Tricot G. "Separating graft-versus-tumor from graft-versus-host reactions." Leukemia and Lymphoma 43(4):. (2002): 725-733-. ( 1/2002 )

• Ashraf Badros, Christopher Morris, Maurizio Zangari, Bart Barlogie, Guido. "Thalidomide Paradoxical Effect on Concomitant Multiple Myeloma and." Leukemia and Lymphoma 43(6):. (2002): 1267-1271-. ( 1/2002 )

• Gary Kohn, Hector R. Wong, Khaled Bshesh, Bin Zhao, Niti Vasi, Alvin Denenberg, Chris Morris, James Stark, Thomas P. Shanley. "Heat Shock inhibits TNF-induced ICAM-1 Expression in Human Endothelial Cells via I kappa kinase (IKK) Inhibition." Shock 17(2):. (2002): 91-7-. ( 1/2002 )

• 21. Badros A, Tricot G, Toor A, Morris C, Guo C, Munshi N, Barlogie B, Cottler-Fox M. "ABO mismatch may affect engraftment in multiple myeloma patients receiving non-myeloablative allogeneic conditioning." Transfusion 42. (2002): 205-209-. ( 1/2002 )

• A Badros, B Barlogie, E Siegle, C Morris, R Desikan, M Zangari, A Toor, A Fassas, E Aniassie, G Tricot. "Autologous stem cell transplant in elderly Multiple Myeloma patients over age 70." British J of Haematology 114. (2001): 600-607-. ( 1/2001 )

• Badros A, Barlogie B, Morris C, Desikan R, Martin SR, Munshi N, Zangari M, Mehta J, Toor A, Cottler-Fox M, Fassas A, Anaissie E, Schichman S, Tricot G. "High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a non-myeloablative conditioning regimen and donor lymphocyte infusions." 97. (2001): 2574-9-. ( 1/2001 )